Dyadic International, Inc. (DYAI)
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
$35.08M
Mr. Mark A. Emalfarb
7.00
Jupiter, FL
Nov 05, 2004
-4.41
$-0.27
3.15
5.39
-429.07%
-4.73
-0.29
11.56
20.42
5.39
-72.82%
-145.95%
Similar stocks (15)
Edgewise Therapeutics, Inc.
EWTX
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
C4 Therapeutics, Inc.
CCCC
DiaMedica Therapeutics Inc.
DMAC
Werewolf Therapeutics, Inc.
HOWL
MediciNova, Inc.
MNOV
PMV Pharmaceuticals, Inc.
PMVP
Champions Oncology, Inc.
CSBR
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
Forte Biosciences, Inc.
FBRX
Kintara Therapeutics, Inc.
KTRA
Kineta, Inc.
KA
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.00765%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (15)
Edgewise Therapeutics, Inc.
EWTX
Celcuity Inc.
CELC
Eliem Therapeutics, Inc.
ELYM
C4 Therapeutics, Inc.
CCCC
DiaMedica Therapeutics Inc.
DMAC
Werewolf Therapeutics, Inc.
HOWL
MediciNova, Inc.
MNOV
PMV Pharmaceuticals, Inc.
PMVP
Champions Oncology, Inc.
CSBR
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
Forte Biosciences, Inc.
FBRX
Kintara Therapeutics, Inc.
KTRA
Kineta, Inc.
KA
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.00765%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%